Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1

Journal of Neuroscience

Volumn 21, Issue 4, 2001, Pages 1110-1116

  Kim, Haesun A ^a   Ratner, Nancy ^b   Roberts, Thomas M ^a   Stiles, Charles D ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

cAMP; Cell cycle; Cyclin D1; Neurofibromatosis; Platelet derived growth factor; Schwann cell

Indexed keywords

CYCLIC AMP; CYCLIN D1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; DRUG MECHANISM; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; TUMOR SUPPRESSOR GENE;

EID: 0035866093     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-04-01110.2001     Document Type: Article

References (35)

1. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
2. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve
3. Purification and preliminary characterization of a glial growth factor from the bovine pituitary
4. cAMP antagonizes p21ras-directed activation of extracelluar signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor
5. Mechanism of action of platelet-derived growth factor
6. Inhibition by cAMP of ras-dependent activation of raf
7. Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells
8. Platelet derived growth factor stimulates Schwann cell DNA synthesis
9. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis
10. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
11. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells
12. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides
13. Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons
14. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
15. Schwann cells: Early Iineage, regulation of proliferation and control of myelin formation
16. cAMP-dependent protein kinase A is required for Schwann cell growth: Interactions between the cAMP and neuregulin/tyrosine kinase pathways
17. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: Reversion of some phenotypes by an inhibitor of farnesyl protein transferase
18. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1
19. Cyclin D1 is an essential mediator of apoptotic neuronal cell death
20. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
21. Identification and purification of glial growth factor
22. A Schwann cell mitogen accompanying regeneration of motor neurons
23. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
24. Schwann cells and cells in the oligodendrocyte lineage proliferate in response to a 50,000 dalton membrane-associated mitogen present in developing brain
25. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
26. Induction of DNA synthesis in Balb/c-3T3 cells by serum components: Reevaluation of the commitment process
27. Schwann cell growth factors
28. Increasing cAMP attenuates activation of mitogen-activated protein kinase
29. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17
30. Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth
31. Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: Analysis using platelet-derived growth factor and platelet-poor plasma
32. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors
33. Rescue of a Drosophila NF1 mutant phenotype byprotein kinase A
34. Cell-specific cyclic AMP-mediated induction of the PDGF receptor
35. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae